Researchers identify new type of nanoclusters for targeted imaging-guided combined cancer therapy

NewsGuard 100/100 Score

As a minimally invasive method for cancer therapy at precise locations, NIR-induced photothermal therapy (PTT) has drawn extensively attention. The therapeutic mechanism is the use of photothermal agents (PTAs) in the treatment of tumors,and its therapeutic effect happens only at the tumor site where both light-absorbent and localized laser radiation coexist.

The development of PTAs with NIR-II absorbance, ranging from 1000 nm to 1700 nm, can efficiently improve their penetrating ability and therapeutic effects because of their high penetration depth in the body. Howerever, several disadvantages are associated with these NIR-II responsive PTAs for their use in biomedical areas. Magnetic nanoparticles (MNPs), which boast strong absorption effect in NIR-II, can meet this demand. It has attracted much attention for biomedical applications with its noninvasive imaging function and magnetic-induced targeted ability.

Recently, a research team led by Prof. WANG Hui and Prof. LIN Wenchu of High Magnetic Field Laboratory, Hefei Institutes of Physical Science (HFIPS), the Chinese Academy of Sciences (CAS) reported a new type of NIR-II responsive hollow magnetite nanoclusters (HMNCs), which is made of composed of Fe3O4, mesoporous shell and hollow cavity for targeted imaging-guided combined therapy of cancer.

"HMNC absorbed NIR-II laser and converted it into local heat, therefore we successfully accelerated combination of drug release and chemo-photothermal therapy."

Wang Hui, Professor, High Magnetic Field Laboratory, Hefei Institutes of Physical Science, The Chinese Academy of Sciences

In one-step solvothermal method, they prepared HMNCs with NIR-II absorption at 1066 nm under an external magnetic field (0.5T), which provided photothermal effect on tumor. Besides, as Fe3O4 dissolved in the acid environment, they can convert H2O2 into toxic Hydroxyl radicals, which add chemodynamic effect. What's more, the hollow cavities in HMNCs are good loading places for drug, which also acted as a targeted contrast agent for tumor magnetic resonance imaging.

Further in vivo experiments proved that the combined effect of photothermal, chemo-therapy and chemodynamic therapy of HMNCs has a significant inhibitory effect on mouse tumor growth.

This experiment showed a kind of multifunctional nanocarriers based on NIR-II responsive HMNCs for trimodal cancer therapy.

Source:
Journal reference:

Wang, X., et al. (2021) NIR-II Responsive Hollow Magnetite Nanoclusters for Targeted Magnetic Resonance Imaging-Guided Photothermal/Chemo-Therapy and Chemodynamic Therapy.  Wiley Online Library. doi.org/10.1002/smll.202100794.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Plant-based diets could reduce the chances of disease progression in men with prostate cancer